Implementation of COVID-19 Laboratory Testing Certification Program (CoLTeP) in African Region.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 13 04 2022
accepted: 30 05 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 30 7 2022
Statut: epublish

Résumé

Coronavirus disease 2019 was declared a global pandemic in March 2020 with correct and early detection of cases using laboratory testing central to the response. Hence, the establishment of quality management systems and monitoring their implementation are critical. This study describes the experience of implementing the COVID-19 Laboratory Testing and Certification Program (CoLTeP) in Africa. Private and public laboratories conducting SARS-CoV-2 testing using polymerase chain reaction were enrolled and assessed for quality and safety using the CoLTeP checklists. A total of 84 laboratories from 7 countries were assessed between April 2021 to December 2021 with 52% of these from the private sector. Among them, 64% attained 5 stars and were certified. Section 4 had the highest average score of 92% and the lowest of 78% in Section 3. Also, 82% of non-conformities (NCs) were related to sample collection, transportation, and risk assessments. Non-availability, inconsistency in performing, recording, instituting corrective actions for failed internal and external quality controls were among major NCs reported. Laboratories identified for SARS-CoV-2 testing by public and private institutions mostly met the requirements for quality and safe testing as measured by the CoLTeP checklist.

Identifiants

pubmed: 35899164
doi: 10.3389/fpubh.2022.919668
pmc: PMC9310066
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

919668

Informations de copyright

Copyright © 2022 Maruta, Shumba, Ndlovu, Moyo, Bangure, Kebede and Noumedem Kenfack.

Déclaration de conflit d'intérêts

TM, DB, YK, and JN are employed in Africa Centres for Disease Control and Prevention. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Pathogens. 2020 Apr 26;9(5):
pubmed: 32357545
Afr J Prim Health Care Fam Med. 2020 Oct 02;12(1):e1-e3
pubmed: 33054266

Auteurs

Talkmore Maruta (T)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Edwin Shumba (E)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.

Nqobile Ndlovu (N)

African Society for Laboratory Medicine, Addis Ababa, Ethiopia.

Sikhulile Moyo (S)

Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

Donewell Bangure (D)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Yenew Kebede (Y)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Jaurès Arnaud Noumedem Kenfack (JA)

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH